Is a Patented Strain of Bacillus coagulans Probiotic a Viable Adjunct Therapy for Relieving Symptoms of Rheumatoid Arthritis?
Completed
- Conditions
- rheumatoid arthritisMusculoskeletal - Other muscular and skeletal disorders
- Registration Number
- ACTRN12609000435280
- Lead Sponsor
- David R. Mandel, MD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Subjects were diagnosed with rheumatoid arthritis at least a year prior to the study
Exclusion Criteria
Pregnancy, chronic inflammatory bowel disease, kidney or liver disease, and subjects taking >10 mg/day of prednislone or other probiotic products
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method